LIVE VIDEO: News 19 at 7:00 pm    Watch
 
  • FOLLOW US
Video Player
  • Email
  • share

Jim Cramer Says Buy Celgene on Weakness Over Revlimid

TheStreet's Jim Cramer says Celgene (CELG), which ended Friday's session down more than 4-percent, is a great buy because the drugmaker is led by a great CEO. Cramer says Celgene CEO Robert Hugin has done a great job of diversifying the company's dru

http://www.wltx.com/video/3340979188001/1/Jim-Cramer-Says-Buy-Celgene-on-Weakness-Over-Revlimid http://cdn.newslook.com/46/460340c345701b9cbcb49e09b3d3d09b/images/frame_ext.jpg Jim Cramer Says Buy Celgene on Weakness Over Revlimid TheStreet's Jim Cramer says Celgene (CELG), which ended Friday's session down more than 4-percent, is a great buy because the drugmaker is led by a great CEO. Cramer says Celgene CEO Robert Hugin has done a great job of diversifying the company's dru jim cramerFinanceyoutubeYahoo!newslookCelgeneUnited Kingdom 01:10

Next Up

    

More Videos